search
Back to results

Sustained Lung Inflation With CPAP in Preterm Neonates (SI-CPAP) (SI-CPAP)

Primary Purpose

RDS of Prematurity

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Sustained lung inflation
Continuous positive airway pressure (CPAP)
Mechanical ventilation
Sponsored by
Ain Shams University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for RDS of Prematurity focused on measuring Sustained lung inflation, Lung injury, Delivery room management, CPAP

Eligibility Criteria

undefined - 6 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Gestational age between 28 weeks (and 0 days) and 34 weeks (and 6 days)
  2. Postnatal age <6 hours
  3. Respiratory distress syndrome diagnosed by both clinical findings of subcostal retractions, tachypnea (>70 breaths/min), the need for respiratory support to maintain oxygen saturation > 87% and X-ray findings of RDS
  4. Application of early CPAP <6 hours of age
  5. Oxygen requirement (FiO2 >30% to maintain preductal saturation 87% - 93%)

Exclusion Criteria:

  • Before enrollment: infants will not be considered in the study if any of the following conditions exists: major congenital anomalies, severe hemodynamic instability indicative of early septicemia, use of inotropes, severe metabolic acidemia with base deficit >12 mEq/dl, frequent apnea / bradycardia (6 episodes per day with HR <100 or 2 episodes per day with HR<60 requiring bag-and-mask ventilation), maternal chorioamnionitis (fever >38 degree Celsius with abdominal tenderness) and PPROM >18 hours, and perinatal hypoxia (Apgar score < 6 at 5 minutes)
  • After enrollment: infants will be eliminated from the study if the initial blood culture on admission is positive.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Experimental

    Active Comparator

    Arm Label

    Group A

    Group B

    Group C

    Arm Description

    Infants in the group receive CPAP for respiratory support in the delivery room. In addition, they receive a total of 15 sustained lung inflations in the first 96 hours of life; 6 in the first day, 3 in the second day, 3 in the third day and 3 in the forth day of life.

    Infants in the group receive CPAP for respiratory support in the delivery room. No sustained lung inflation will be applied.

    Infants in this group are intubated in the delivery room and supported with mechanical ventilation.

    Outcomes

    Primary Outcome Measures

    Serum concentration of cytokines
    IL-6, IL-8, IL-1β, - TNF-α and elastase will be measured in all subjects in group, group B, and group C.

    Secondary Outcome Measures

    Oxygen requirement
    Fraction of inspired oxygen (FiO2) while on CPAP

    Full Information

    First Posted
    April 13, 2019
    Last Updated
    April 17, 2019
    Sponsor
    Ain Shams University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03916523
    Brief Title
    Sustained Lung Inflation With CPAP in Preterm Neonates (SI-CPAP)
    Acronym
    SI-CPAP
    Official Title
    Effect of Sustained Lung Inflation During CPAP in Preterm Neonates With Respiratory Distress Syndrome
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2019
    Overall Recruitment Status
    Completed
    Study Start Date
    January 1, 2013 (Actual)
    Primary Completion Date
    March 15, 2016 (Actual)
    Study Completion Date
    March 15, 2016 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Ain Shams University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Neonatal respiratory distress syndrome (RDS) is the most common cause of respiratory failure in the first few days in life. It is characterized by the tendency of alveoli and terminal bronchioles to collapse due to the lack of surfactant. RDS is inversely related to gestational age and remains a dominant clinical problem encountered among preterm infants. The reduction in tidal volume secondary to alveolar collapse may result in alveolar derecruitment, cyclic opening and closing of atelectatic alveoli and distal small airways leading to inflammation and lung injury). On the other hand, the use of high positive end expiratory pressure (PEEP) may be associated with excessive lung parenchyma strain and unfavorable hemodynamic effects. Therefore, lung recruitment maneuvers have been proposed and used to open collapsed lung while managing with low pressure PEEP. However, the best recruitment maneuver technique is currently unknown. Proinflammatory cytokines are synthesized by alveolar macrophages, type II pneumocytes and other local pulmonary cells causing inflammation that starts a cascade leading to lung injury. Nevertheless, they are released systemically and can lead to injury of other organs. This study aims to measure inflammatory cytokines in the serum of premature infants who receive and do not receive sustained lung inflation. The study hypothesis is that, in premature infants supported with CPAP, the use of sustained inflation is associated with decreased inflammatory biomarkers and improved respiratory outcomes. The study includes infants with gestational age of 28-24 weeks during the first 6 hours of life who will be randomly assigned to either receive (or do not receive) sustained inflations. Serum concentrations of cytokines (IL-6, IL-8, IL-1β and TNF-α) will be measured at enrollment and at 96 hours. The primary outcome of this study will be the change in serum cytokine concentrations after intervention in both groups. Clinical respiratory outcomes will be monitored.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    RDS of Prematurity
    Keywords
    Sustained lung inflation, Lung injury, Delivery room management, CPAP

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigator
    Masking Description
    All laboratory testing will be performed by investigators who are not aware of group assignment.
    Allocation
    Non-Randomized
    Enrollment
    100 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Group A
    Arm Type
    Experimental
    Arm Description
    Infants in the group receive CPAP for respiratory support in the delivery room. In addition, they receive a total of 15 sustained lung inflations in the first 96 hours of life; 6 in the first day, 3 in the second day, 3 in the third day and 3 in the forth day of life.
    Arm Title
    Group B
    Arm Type
    Experimental
    Arm Description
    Infants in the group receive CPAP for respiratory support in the delivery room. No sustained lung inflation will be applied.
    Arm Title
    Group C
    Arm Type
    Active Comparator
    Arm Description
    Infants in this group are intubated in the delivery room and supported with mechanical ventilation.
    Intervention Type
    Procedure
    Intervention Name(s)
    Sustained lung inflation
    Intervention Description
    Preterm infants will receive a total of 15 sustained lung inflations during the first 4 days of life as follows: On day 1 of life (a total of 6 sustained lung inflations, 20 cmH2O for 21 seconds each) once at enrollment and then once every 4 hours On day 2 of life (a total of 3 sustained lung inflations, 15 cmH2O for 21 seconds each) once every 8 hours. On day 3 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours. On day 4 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours.
    Intervention Type
    Procedure
    Intervention Name(s)
    Continuous positive airway pressure (CPAP)
    Other Intervention Name(s)
    CPAP
    Intervention Description
    Preterm infants will receive CPAP for respiratory support.
    Intervention Type
    Procedure
    Intervention Name(s)
    Mechanical ventilation
    Intervention Description
    Preterm infants in this group will receive mechanical ventilation for respiratory support
    Primary Outcome Measure Information:
    Title
    Serum concentration of cytokines
    Description
    IL-6, IL-8, IL-1β, - TNF-α and elastase will be measured in all subjects in group, group B, and group C.
    Time Frame
    At 96 hours of life
    Secondary Outcome Measure Information:
    Title
    Oxygen requirement
    Description
    Fraction of inspired oxygen (FiO2) while on CPAP
    Time Frame
    At 96 hours of life

    10. Eligibility

    Sex
    All
    Maximum Age & Unit of Time
    6 Hours
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Gestational age between 28 weeks (and 0 days) and 34 weeks (and 6 days) Postnatal age <6 hours Respiratory distress syndrome diagnosed by both clinical findings of subcostal retractions, tachypnea (>70 breaths/min), the need for respiratory support to maintain oxygen saturation > 87% and X-ray findings of RDS Application of early CPAP <6 hours of age Oxygen requirement (FiO2 >30% to maintain preductal saturation 87% - 93%) Exclusion Criteria: Before enrollment: infants will not be considered in the study if any of the following conditions exists: major congenital anomalies, severe hemodynamic instability indicative of early septicemia, use of inotropes, severe metabolic acidemia with base deficit >12 mEq/dl, frequent apnea / bradycardia (6 episodes per day with HR <100 or 2 episodes per day with HR<60 requiring bag-and-mask ventilation), maternal chorioamnionitis (fever >38 degree Celsius with abdominal tenderness) and PPROM >18 hours, and perinatal hypoxia (Apgar score < 6 at 5 minutes) After enrollment: infants will be eliminated from the study if the initial blood culture on admission is positive.

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    21276671
    Citation
    Abdel-Hady H, Shouman B, Aly H. Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial. Early Hum Dev. 2011 Mar;87(3):205-8. doi: 10.1016/j.earlhumdev.2010.12.010. Epub 2011 Jan 26.
    Results Reference
    background
    PubMed Identifier
    19651592
    Citation
    Aly H. Ventilation without tracheal intubation. Pediatrics. 2009 Aug;124(2):786-9. doi: 10.1542/peds.2009-0256. Epub 2009 Jul 27. No abstract available.
    Results Reference
    background
    PubMed Identifier
    12464497
    Citation
    Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol. 2002 Oct;7(5):353-60. doi: 10.1053/siny.2002.0129.
    Results Reference
    background
    PubMed Identifier
    20616570
    Citation
    Lista G, Fontana P, Castoldi F, Cavigioli F, Dani C. Does sustained lung inflation at birth improve outcome of preterm infants at risk for respiratory distress syndrome? Neonatology. 2011;99(1):45-50. doi: 10.1159/000298312. Epub 2010 Jul 9.
    Results Reference
    background

    Learn more about this trial

    Sustained Lung Inflation With CPAP in Preterm Neonates (SI-CPAP)

    We'll reach out to this number within 24 hrs